Product Information
SM TRIPLE ANTIBIOTIC PLUS OINT is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.1284 per GM under NDC 49348060072. Its NADAC has been published 622 times since Nov 28, 2013.
SM TRIPLE ANTIBIOTIC PLUS OINT
polymyxin B sulfate, bacitracin zinc, neomycin sulfate, and pramoxine hydrochlorideStrength
500; 3.5; 10000; 10 [iU]/g; mg/g; [iU]/g; mg/g
Manufacturer
Strategic Sourcing Services LLCNDC
49348060072
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
10/22/2025
Approval Type
OTC MONOGRAPH DRUG
FDA Application
M004On Market Since
3/31/2012
Pharmacological Classes
Price Statistics
The NADAC for SM TRIPLE ANTIBIOTIC PLUS OINT has been published 622 times since Nov 28, 2013, and over the history we have for it it has declined 16.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1284 per GM |
|---|---|
| All-time high | $0.1731 (Feb 11, 2015) |
| All-time low | $0.1226 (Apr 19, 2017) |
| 52-week high | $0.1284 |
| 52-week low | $0.1266 |
| Median price | $0.1324 |
| Average price | $0.1341 |
| Largest weekly change | -26.2% (Dec 2, 2015) |
| Weeks tracked | 622 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+1.5%
3Y
-7.4%
5Y
-1.0%
All
-16.8%
Last surveyed Oct 22, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the polymyxin B sulfate, bacitracin zinc, neomycin sulfate, and pramoxine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
polymyxin B sulfate, bacitracin zinc, neomycin sulfate, and pramoxine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SM TRIPLE ANTIBIOTIC PLUS OINT?
The current National Average Drug Acquisition Cost (NADAC) for SM TRIPLE ANTIBIOTIC PLUS OINT, manufactured by Strategic Sourcing Services LLC, is $0.1284 per GM (NDC 49348060072), effective Oct 22, 2025.
How has the price of SM TRIPLE ANTIBIOTIC PLUS OINT changed over time?
Over the history we have for it, the NADAC for SM TRIPLE ANTIBIOTIC PLUS OINT has declined 16.8%. It has been tracked across 622 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SM TRIPLE ANTIBIOTIC PLUS OINT?
Since Nov 28, 2013, the NADAC for SM TRIPLE ANTIBIOTIC PLUS OINT has ranged from a low of $0.1226 (Apr 19, 2017) to a high of $0.1731 (Feb 11, 2015), with a median of $0.1324 per GM.
Are there cheaper alternatives to SM TRIPLE ANTIBIOTIC PLUS OINT?
No other NADAC-published product currently shares the active ingredient and strength of SM TRIPLE ANTIBIOTIC PLUS OINT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SM TRIPLE ANTIBIOTIC PLUS OINT?
SM TRIPLE ANTIBIOTIC PLUS OINT (NDC 49348060072) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.